About Oneiro Chemicals
Oneiro Chemicals is a Healthcare company based in Vadodara (India) founded in 2004 by Pranav Dushyant Patel. Active Pharmaceutical Ingredients and intermediates are manufactured. Oneiro Chemicals has raised $253.68 thousand across 1 funding round from investors including Transpekfinance. The company has 405 employees. Oneiro Chemicals was last valued at $1.52 million in January 2008. Its Indian entity Oneiro Lifecare Private Limited reported revenue of ₹367 Cr. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Its competitors include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed competitors have raised funding.
Company details
Oneiro Chemicals was established in 2004 in Vadodara, India, within the pharmaceutical sector. Active Pharmaceutical Ingredients including Dextromethorphan HBr, Omeprazole, Esomeprazole Mg-Trihydrate, Folic Acid, and Pregabalin are produced. Intermediates for Omeprazole, Dextromethorphan HBr, Carvedilol, Lamotrigine, and Quinoline Phosphate are also manufactured. Operations center on API and intermediate production for pharmaceutical applications.
- Headquarters Vadodara, India
- Employees 405
- Founders Pranav Dushyant Patel
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website oneirochemicals.net
- Social LinkedIn X Facebook
- Legal Name Oneiro Lifecare Private Limited
- Date of Incorporation 27 Oct, 2004
- Jurisdiction Vadodara, Gujarat, India
- Annual Revenue₹367 Cr
FY 2025 · +14% YoY
- Net Profit₹32.25 Cr
FY 2025 · 9% margin
- EBITDA₹51.67 Cr
FY 2025 · 14% margin
- Total Equity Funding$253.68K (USD)
in 1 rounds
- Latest Funding Round$253.68K (USD), Seed
Jan 2008
- Employee Count405
Associated legal entities of Oneiro Chemicals
Oneiro Chemicals is associated with 2 registered companies on The Company Check; the primary company is Oneiro Lifecare Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Oneiro Lifecare Private Limited CIN U24230GJ2004PTC044960 | Active | 27 Oct 2004 | Vadodara, Gujarat | ₹367 Cr | 405 | 4 | View details |
| Dharmmanandan Hr Talent Management System Llp CIN ABB-6314 | Active | 07 Jul 2022 | Vadodara, Gujarat | 2 | View details |
Funding Insights of Oneiro Chemicals
Oneiro Chemicals has successfully raised a total of $253.68K through 1 strategic funding round. The most recent funding activity was a Seed round of $253.68 thousand completed in January 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $253,678
- Total Rounds 1
- Last Round Seed — $253,678
- First Round $253,678
(Jan 2008)
- Investors Count 1
All 1 funding rounds of Oneiro Chemicals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2008 | $253,678 | Seed | $1.52M | Transpekfinance | – |
| Date | Valuation | Stage |
|---|---|---|
| Jan 2008 | $1.52M | •••••••• |
Last known valuation $1.52M (Jan 2008). 1 investors in total: 1 institutional.
Investors in Oneiro Chemicals
Oneiro Chemicals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Transpekfinance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investor details for Oneiro Chemicals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Oneiro Lifecare Private Limited (Oneiro Chemicals)
Oneiro Lifecare Private Limited is the primary company behind Oneiro Chemicals. The boards of the 2 registered companies of Oneiro Chemicals currently have 6 directors; the longest-serving is Chirag Chandrakant Kansara, appointed in 2017. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Chirag Chandrakant Kansara DIN 07862918 | Whole-time director | 29 Jun 2017 | 9 yrs 4 mo | Oneiro Lifecare Private Limited |
| Pranav Dushyant Patel DIN 00009820 | Managing Director | 01 Nov 2017 | 9 yrs | Oneiro Lifecare Private Limited |
| Dushyant Dahyabhai Patel DIN 00009714 | Director | 01 Nov 2017 | 9 yrs | Oneiro Lifecare Private Limited |
| Reshmaben Darshankumar Patel DIN 10009762 | Designated Partner | 07 Jul 2022 | 4 yrs 3 mo | Dharmmanandan Hr Talent Management System Llp |
| Kanan Jainik Dave DIN 10063138 | Designated Partner | 07 Mar 2023 | 3 yrs 7 mo | Dharmmanandan Hr Talent Management System Llp |
| Darshankumar Shantilal Patel DIN 10692725 | Whole-time director | 03 Jul 2024 | 2 yrs 4 mo | Oneiro Lifecare Private Limited |
People of Oneiro Chemicals
1 people are tracked at Oneiro Chemicals (1 in leadership); the tracked headcount is 405.
| Name | Role | Group |
|---|---|---|
| Founder & Managing Director | Leadership |
Complete people profiles for Oneiro Chemicals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Oneiro Chemicals
Figures of Oneiro Lifecare Private Limited, the primary company behind Oneiro Chemicals, for FY 2025. Revenue was ₹367 Cr (+14% year on year). Net profit was ₹32.25 Cr (9% margin). EBITDA was ₹51.67 Cr (14% margin). Revenue has grown at a compounded annual rate of +17% over three years and +18% over five years.
- ₹367 CrRevenue · FY 2025 · +14% YoY
- ₹32.25 CrNet profit · 9% margin
- ₹51.67 CrEBITDA · 14% margin
- ₹1.54 CrPaid-up capital
- 405Employees (provident fund records)
- +17%Revenue CAGR, 3 years
- +18%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Oneiro Lifecare Private Limited are on its company page.
Detailed financial statements for Oneiro Chemicals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Oneiro Chemicals
3 dated milestones of Oneiro Chemicals across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Oneiro Chemicals is founded.
- Funding First funding round of $254K.
- Milestone Reaches Minicorn status.
Competitors of Oneiro Chemicals
Oneiro Chemicals has 3 listed competitors in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed competitors of Oneiro Chemicals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Oneiro Chemicals (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Oneiro Chemicals
Complete news archive for Oneiro Chemicals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oneiro Chemicals
Oneiro Chemicals was founded in 2004 and raised its 1st funding round 4 years after it was founded.
Oneiro Chemicals is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.
Oneiro Chemicals is a funded company, having raised a total of $253.68K across 1 funding round to date. The company's 1st funding round was a Seed of $253.68K, raised on Jan 2008.
Oneiro Chemicals has 405 employees.
The primary company behind Oneiro Chemicals, Oneiro Lifecare Private Limited, reported revenue of ₹367 Cr for FY 2025, up 14% year on year.
Oneiro Chemicals was established in 2004 in Vadodara, India, within the pharmaceutical sector. Active Pharmaceutical Ingredients including Dextromethorphan HBr, Omeprazole, Esomeprazole Mg-Trihydrate, Folic Acid, and Pregabalin are produced. Intermediates for Omeprazole, Dextromethorphan HBr, Carvedilol, Lamotrigine, and Quinoline Phosphate are also manufactured. Operations center on API and intermediate production for pharmaceutical applications.
Oneiro Chemicals's top competitors include Laurus Labs, Symbiotec and SeQuent.
Oneiro Chemicals has 1 investor. Key investors include Transpekfinance.
The valuation of Oneiro Chemicals is $1.52M as of Jan 2008.
Oneiro Chemicals is associated with 2 legal entities: Oneiro Lifecare Private Limited, Dharmmanandan Hr Talent Management System Llp.
The legal entities of Oneiro Chemicals currently have 6 directors, including Reshmaben Darshankumar Patel, Kanan Jainik Dave, Pranav Dushyant Patel and others.